Here's why AMP Limited is now the greatest blue-chip growth stock

AMP Limited (ASX:AMP) is arguably now the most China focussed blue-chip stock outside of the mining giants.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Leading blue-chip wealth advisor AMP Limited (ASX: AMP) has announced plans to acquire a 19.9% stake in China Life Pension Company for $240 million.

China Life Pension Company is China's largest pension company and the acquisition further strengthens the ties between AMP and parent company China Life Insurance Company, China's largest listed life insurance group, a relationship which goes back to 2005.

So what: Currently the size of the Chinese enterprise annuities (EA) pension market is only $112 billion. That's tiny when you consider the population. Unsurprisingly, the EA market is forecast to grow exponentially – by 2020, AMP suggests the market will grow to $717 billion.

Given Australia's highly regarded superannuation system and AMP's leading position within it, AMP has a huge amount of experience and know-how that it can export to China. The sheer size of China's rapidly growing middle class makes for an enticing opportunity and certainly a major growth opportunity for AMP which is otherwise constrained by a very mature domestic market.

Now what: AMP's share price has jumped 1.2% higher on Friday morning post announcement with the shares now trading within a whisker of their 52-week high price of $5.95. It's been a great 12-month period for shareholders with the stock having now rallied 22.8%.

Management has commented that it expects the acquisition to be earnings per share accretive from 2017 with no material dilution in 2015 or 2016. Currently, analyst consensus data from Morningstar suggests AMP will earn 38.9 cents per share in FY 2015. On that basis the stock is trading on a price-to-earnings ratio of 15x, which is roughly in line with the market multiple. Once analysts account for the potential growth that this acquisition will bring, it is highly likely that earnings upgrades for FY 2017 and beyond will occur. This could lead to the stock being re-rated and could make now an opportune time to acquire shares.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »